BPA Call 36C25921A0036-36C25924N0251
Award Date 5/1/24
Potential Completion Date 4/30/25
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84148, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide its Prolaris prostate cancer genetic testing services to the U.S. Department of Veterans Affairs (VA). The contract, with a ceiling value of $6,000.00, is a firm fixed-price delivery order that supports disease risk stratification and treatment planning for veterans served by the VA healthcare system, including the Salt Lake City VA Medical Center. Myriad Genetics Inc. has been...
- This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
- The U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 22 (VISN 22), awarded a firm-fixed-price purchase order to Myriad Genetics Inc. for $154,938.00 to provide Prolaris genetic testing services. Prolaris is a molecular diagnostic test that measures gene expression levels to assess prostate cancer aggressiveness. This contract is for the VA Long Beach Healthcare System to utilize Myriad's Prolaris testing capabilities on an as-needed basis from...
- This federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., is for a Firm Fixed Price Purchase Order of $7,946.32 to provide MYRIAD GENETIC TESTING services. The contract, awarded by the Defense Health Agency, has an ultimate completion date of February 25, 2017. Myriad Genetic Laboratories Inc. is a for-profit company that specializes in genetic testing and precision medicine services. The primary service provided under this contract is the Prolaris...
- This federal contract award to Myriad Genetics Inc. is for a Blanket Purchase Agreement (BPA) call valued at $100,000 to provide genetic testing services related to cancer diagnostics and risk assessment. The contract was awarded by the Defense Health Agency, a component of the Department of Defense, to deliver Myriad's Prolaris quantitative PCR testing on prostate biopsy samples. The Prolaris test helps assess tumor aggressiveness and guide treatment approaches for prostate cancer patients....
- This federal contract award is for the delivery of Prolaris genetic testing services to the U.S. Department of Veterans Affairs (VA). The prime contractor is Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. that specializes in personalized medicine and genetic testing. The contract was awarded by the VA's Veterans Integrated Service Network 12 (VISN 12) and the VA Salt Lake City Health Care System. It includes two Indefinite Delivery Vehicles (IDVs) - an Indefinite Delivery...
- This federal contract award with ID HT001417A0029|HT001419F0321 was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company, for Myriad's Prolaris genetic testing services. The $100,000.00 firm-fixed-price contract is for quantitative PCR analysis and reporting to assess prostate cancer aggressiveness and guide treatment approaches. This appears to be a Blanket Purchase Agreement (BPA) call, with Myriad Genetics having been awarded multiple prior BPA calls...
- This is a firm fixed price delivery order awarded to Myriad Genetic Laboratories Inc., a leading genetic testing and precision medicine company, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $10,982 contract is for the provision of Prolaris prostate cancer testing services to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network 12. Myriad Genetic Laboratories previously held a $149,600...
- This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...
- This is a firm-fixed-price contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The $95,000.00 contract is for the provision of various genetic testing services, with a focus on Prolaris prostate cancer testing. The contract is a Blanket Purchase Agreement (BPA) call, allowing the Department of Veterans Affairs (VA) to efficiently procure Myriad's specialized genetic testing services across multiple regions....